Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Acute Respiratory Distress Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04582201
What this trial is testing

A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS

Who this might be right for
Respiratory Distress Syndrome, Adult
MiNK Therapeutics 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05938036
What this trial is testing

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

Who this might be right for
Acute Respiratory Distress Syndrome (ARDS)
Aqualung Therapeutics Corp. 15
Early research (Phase 1)Ended earlyNCT04609943
What this trial is testing

Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)

Who this might be right for
Acute Respiratory Distress Syndrome
Bayer 16
Not applicableNot Yet RecruitingNCT07334873
What this trial is testing

Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress Syndrome

Who this might be right for
ARDS (Moderate or Severe)
Nanfang Hospital, Southern Medical University 536
Not applicableUnknownNCT05056090
What this trial is testing

Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome.

Who this might be right for
ARDSAcute Respiratory Distress SyndromeIntensive Care Unit+1 more
University Hospital, Grenoble 656
Not applicableStudy completedNCT02570217
What this trial is testing

HHHFNC (Heated Humidified High-Flow Nasal Cannula) Versus NCPAP for Respiratory Distress Syndrome of Prematurity

Who this might be right for
Newborn Respiratory Distress Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 316
Not applicableUnknownNCT06514209
What this trial is testing

Effect of Different Depths of Neuromuscular Blockade on Respiratory Mechanics in Patients With Moderate-severe Acute Respiratory Distress Syndrome

Who this might be right for
ARDSLung Protective Ventilation
Southeast University, China 20
Not applicableStudy completedNCT07803614
What this trial is testing

Pressure Release Ventilation Compared to Lung Protective Ventilation in Moderate and Severe ARDS

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
Koot Ahmad 60
Not applicableLooking for participantsNCT06212492
What this trial is testing

Effects on Biotrauma of NMBAs and PP Association During ARDS

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome
Assistance Publique Hopitaux De Marseille 40
Not applicableLooking for participantsNCT06430554
What this trial is testing

Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability

Who this might be right for
Respiratory Distress SyndromePositive-Pressure RespirationMechanical Ventilation
Zhongda Hospital 40
Not applicableLooking for participantsNCT07807046
What this trial is testing

TwichView-guided Atricurium Dose Adjustment Trial

Who this might be right for
ARDSTTMECMO+1 more
Fu Jen Catholic University Hospital 120
Not applicableUnknownNCT04619667
What this trial is testing

Effects of a New Interface for NIV on Respiratory Drive

Who this might be right for
Acute Respiratory Failure
University Magna Graecia 22
Testing effectiveness (Phase 2)WithdrawnNCT03376854
What this trial is testing

Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS

Who this might be right for
Respiratory Distress Syndrome, AdultSars-CoV2
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Looking for participantsNCT07413978
What this trial is testing

A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome

Who this might be right for
Acute Respiratory Distress Syndrome
Changchun Tuohua Pharmaceutical Co., Ltd. 36
Not applicableStudy completedNCT02606240
What this trial is testing

Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG

Who this might be right for
Acute Respiratory Distress Syndrome
Groupe Hospitalier Pitie-Salpetriere 20
Not applicableStudy completedNCT03303807
What this trial is testing

Correction by ECCO2-R of Hypercapnia in Patients With DVP in Moderate to Severe ARDS Under Protective Ventilation.

Who this might be right for
Acute Respiratory Distress SyndromeHypercapnia
Assistance Publique - Hôpitaux de Paris 8
Testing effectiveness (Phase 2)UnknownNCT05947747
What this trial is testing

Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS

Who this might be right for
ARDS
Nano24med 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07706855
What this trial is testing

Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
Beijing Gene Key Life Technology Co., Ltd 52
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Next Page